Presiese radioterapie is die belangrikste metode van kankerbehandeling. Presiese radioterapie tegnieke verteenwoordig deur vinnige voormes, protonmes, swaar ioon, ens., kan radikale chirurgie en hulpbehandeling vir kankerpasiënte uitvoer. To understand the progress of radiotherapy, sarcoma is more common in young people, is a malignant tumor derived from mesenchymal tissue (including connective tissue and muscle). Sarcomas are highly malignant and develop rapidly! Common sarkome include osteosarcoma, leiomyoma, lymphosarcoma, synovial sarcoma, etc.
Die voorkeurmetode van sarkoom is chirurgie. Om 'n radikale genesing te soek, vereis huisdokters gewoonlik dat pasiënte hul ledemate moet amputeer. , Die meeste pasiënte is moeilik om te behandel. Sarkome is nie sensitief vir chemoterapie nie. Gewone radioterapie is ook moeilik om gewasse dood te maak, en leiomyoom, limfosarkoom en sinoviale sarkoom is geneig tot metastase deur die bloed. Daarom moet die behandeling van sarkoom so gou as moontlik en so gou as moontlik wees.
The EDGE Radiosurgery system (EDGE radiosurgery tumor treatment system) was developed by the American Varian company and was approved by the US FDA on January 23, 2013. The EDGE blade is by far the most effective non-invasive tumor removal technology, using the unique FDA’s Calypso® GPS for the Body® system and surface beam monitoring system approved on July 21, 2014 with high-frequency real-time dynamics of up to 10 ms Monitor and lock the tumor “escape” during the treatment process, combined with the new generation IGRT and other image guidance technology, using the unique high-intensity HD-MLC collimator up to 2400MU / min to remove tumor tissue with sub-millimeter accuracy with almost no residue .
Die unieke eienskappe van EDGE-spoedmes, hoë-intensiteit bestraling van tot 2400MU / min, kan vinnig die DNA van tumorselle breek, en uiteindelik veroorsaak dat die tumorselle sterf, en die gewas word geabsorbeer of littekens kry. Die akkuraatheid van die EDGE-mes is so hoog as 0.1 mm.
